Featured Research

from universities, journals, and other organizations

Aspirin Component Prevents Antibiotic-Induced Deafness

Date:
July 14, 1999
Source:
University Of Michigan
Summary:
University of Michigan scientists have found that salicylate---the active component of ordinary aspirin---can prevent deafness in guinea pigs exposed to a common class of antibiotics that destroy delicate hair cells in the inner ear. Results of the study are published in the July 1999 issue of the journal Laboratory Investigation.

ANN ARBOR -- University of Michigan scientists have found that salicylate---the active component of ordinary aspirin---can prevent deafness in guinea pigs exposed to a common class of antibiotics that destroy delicate hair cells in the inner ear. Results of the study are published in the July 1999 issue of the journal Laboratory Investigation.

A clinical trial currently under way at a hospital in Xi'an, China, will determine whether aspirin is as effective in people as it is in guinea pigs, according to Jochen Schacht, Ph.D., a biochemist in the otolaryngology department of the U-M Medical School and a consultant on the clinical trial.

Discovered in the 1940s, aminoglycosides---which include streptomycin, gentamicin, neomycin and others---are the most widely used antibiotics in the world even though they are known to cause hearing loss and balance disorders in a significant percentage of individuals who take them.

"These drugs are a serious problem in rural areas of developing countries, especially China and Southeast Asia, where they are widely used because they are so effective and inexpensive," Schacht said. "All too frequently, they are the only affordable drugs available. Studies of deaf-mutism in southeastern China showed that two-thirds of the cases were caused by aminoglycosides."

In the United States and other industrialized countries, aminoglycosides are most often used to treat people with serious infections who have not responded to other antibiotics. "The increasing worldwide threat of antibiotic-resistant tuberculosis in the wake of AIDS, however, makes it likely that their use will increase in the future," Schacht added.

After years of research, Schacht and his colleagues reported in 1995 that gentamicin combines with iron in the body to trigger production of free radicals---unstable molecules that rip apart and damage cells. Thousands of tiny hair cells in the inner ear are especially vulnerable. Without functional hair cells, the inner ear is unable to detect sounds or transmit signals to auditory neurons leading to the brain. The result is irreversible hearing loss.

In 1997, Schacht published the results of experiments showing that iron chelators---medications used to "soak up" excess iron in the bloodstream---protected guinea pigs from gentamicin's ototoxic effects. One of the chelators tested was 2,3-dihydroxybenzoate or DHB.

In an effort to develop a simple and clinically feasible way to prevent hair cell damage, Schacht and Su-Hua Sha, M.D., a research associate in the U-M Medical School, modified the experiment using a related compound called 2-hydroxybenzoate or salicylate. "Aspirin breaks down to salicylate in the body within 15 to 20 minutes," Schacht said.

In the current study, one group of guinea pigs received injections of gentamicin. Another group received gentamicin and salicylate. A control group received saline solution. All animals were given hearing tests before, during and after treatment. The quantity and physical condition of hair cells in the cochlea or inner ear of the animals were examined at the conclusion of the experiment.

Guinea pigs receiving gentamicin alone had profound hearing loss, up to 70 decibels at some wavelengths, and almost complete destruction of the outer hair cells in the cochlea. Animals receiving gentamicin and salicylate had minor hearing impairment of less than 20 decibels and minimal hair cell damage. The low salicylate doses used in the experiment had no effect on guinea pig auditory thresholds. Use of salicylate did not lower the blood serum levels of gentamicin, nor did it affect the antibiotic's ability to kill E. coli bacteria.

"Salicylate levels providing protection in guinea pigs fall into the lower range recommended for anti-inflammatory therapy in humans," Sha added. "The required serum levels could easily be achieved with moderate doses of aspirin."

The research was funded by the National Institute on Deafness & Other Communication Disorders, National Institutes of Health. The experiments were conducted at the U-M's Kresge Hearing Research Institute.


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "Aspirin Component Prevents Antibiotic-Induced Deafness." ScienceDaily. ScienceDaily, 14 July 1999. <www.sciencedaily.com/releases/1999/07/990714073055.htm>.
University Of Michigan. (1999, July 14). Aspirin Component Prevents Antibiotic-Induced Deafness. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1999/07/990714073055.htm
University Of Michigan. "Aspirin Component Prevents Antibiotic-Induced Deafness." ScienceDaily. www.sciencedaily.com/releases/1999/07/990714073055.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins